Last updated on September 2018

Genetics of QT Prolongation With Antiarrhythmics


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: overdose of drug with toxic effect | Long QT Syndrome
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • All patients admitted for dovetailed or sotalol initiation for clinical purposes.

Exclusion Criteria:

  • Inability to provide informed consent
  • Inability to provide blood samples for DNA testing (anemia, coagulopathy)

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.